Smallpox Vaccine Has "No Serious Side Effects,"
Military Study Concludes
Sgt. 1st Class Doug Sample
American Forces Press Service
WASHINGTON, June 25, 2003 - Mass smallpox
vaccinations can be conducted safely with "very low" rates of
serious adverse effects, the Defense Department's senior medical
official said today.
And the military will continue with its vaccination program
because the smallpox bioterror threat remains, said Dr. William
Winkenwerder, assistant secretary of defense for health affairs,
during a press briefing at the National Press Club.
"Although we are no longer vaccinating service members at the
rate we witnessed earlier in the program, we continue to vaccinate
those who are serving or who soon will be serving in high-risk
areas," he noted.
"Our experience demonstrates that on a large scale the smallpox
vaccination program can be conducted safely," Winkenwerder said.
DoD's top doctor pointed out that there are risks associated with
the smallpox vaccination, even though significant side effects are
rare and death, very rare. But, he added, "Our experience is that it
is possible to reduce those risks associated with the vaccine."
According to information from the five and a half-month military
study, DoD administered 450,293 smallpox vaccinations, including
more than 50,000 per week at the peak of the military vaccination
program.
The study began Dec. 13, 2002, the day after President Bush
announced the plan to vaccinate the military, and ended May 28,
2003.
During that period, the military began vaccinating selected
military personnel in a national program of preparedness against the
use of smallpox as a biological weapon.
Army Col. John D. Grabenstein, deputy director for clinical
operations at the Military Vaccine Agency, said the study proved
that the vaccine was administered without many adverse reactions,
such as skin irritation and blister rashes, or risks associated with
the vaccine.
Grabenstein, who along with Winkenwerder co-authored a report on
the vaccination study, said that adverse incidents were not as
apparent as historical data would suggest.
"Itching at the vaccination site was reported by about 60 percent
of those vaccinated," Grabenstein said. In addition, he said that
cases of "blister rashes were mild and that they were treated on an
outpatient basis.
He also noted that only 3 percent needed to take sick leave after
being vaccinated. That leave lasted roughly a day and a half, he
said.
Winkenwerder said key elements of keeping risks to a minimum
during the vaccination program include comprehensive training of
medical staff; education and careful screening of service members to
be vaccinated; close monitoring following vaccination; and early
intervention when adverse events occur.
He noted one very important finding in the study: no cases of
transmission of vaccine virus from the health care worker to the
patient.
But there were some concerns about the study. Winkenwerder said
acute myopericarditis -- inflammation of the membrane covering the
heart - occurred in a small number of service members who received
the vaccine: about 1 in 12,000, or 37, people.
"All of these individuals have recovered or they are recovering
and we will continue to follow them," he said.
Grabenstein also refuted media accounts of the vaccine causing
heart attacks in military personnel.
"We have had several heart attacks among smallpox vaccines, but
no more than we have had among a similar amount of unvaccinated
people," he said. "So our conclusion is that heart attacks and small
pox vaccination are unrelated," he said.
Winkenwerder said that information learned from the study will
provide the American medical community and public with "current,
factual information that will be useful as the U.S. moves forward
with its vaccination program."
The study's results were reported on the Journal of the American
Medical Association's Web site at www.jama.ama-assn.org.
AFRTS Radio and TV Reports:
|